0
0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Company Profile

    $295 | February 2024
    Company Profile

    Emergent BioSolutions Inc – Company Profile

    Emergent BioSolutions Inc (Emergent) is a life sciences company that provides specialized products to address medical needs and public health threats (PHTs). Its solutions help address PHTs including chemical, biological, radiological, travel health, emerging health crises, nuclear and explosives (CBRNE), emerging infectious diseases and acute/emergency care. It offers vaccines, therapeutics, drug-device combination products, and contract development and manufacturing services. Emergent's pipeline candidates target dengue and other influenza infections. It also offers specialized products to governments and commercial customers. The company...

    Add to Basket
  • Company Profile

    $295 | January 2024
    Company Profile

    GlycoMimetics Inc – Company Profile

    GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that discovers and develops small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s lead pipeline product, uproleselan, is being developed for the treatment of relapsed/refractory acute myeloid leukemia (AML) in adults. GlycoMimetics designs galectin inhibitors for advancing treatment options for various diseases. The company designs and tests viral and bacterial entry inhibitors for dendritic cell receptors. The company uses proprietary glycobiology technology to develop treatments for diseases. It...

    Add to Basket
  • Company Profile

    $295 | November 2023
    Company Profile

    MaxCyte Inc – Company Profile

    MaxCyte Inc (MaxCyte) discovers, manufactures, and commercializes cell-based medicines. The company’s products include MaxCyte STX, MaxCyte VLX, MaxCyte GT, ExPERTATx, ExPERTGTx, ExPERTSTx and ExPERTVLx scalable transfection systems, which use the flow electroporation technology for engineering of cells. It is investigating MCY-M11 IP, a mesothelin-targeted therapy for treating ovarian and peritoneal mesothelioma, and MCY-M11 IV therapy for undisclosed solid tumors. MaxCyte provides insourcing services such as instrument training, follow-on experimentation and others. The company developed CARMA, a proprietary technology platform for...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    Federal Realty Investment Trust – Company Profile

    Federal Realty Investment Trust (Federal Realty) is an equity real estate investment trust (REIT) specialized in the ownership, operation, development, and redevelopment of retail-based properties. The trust's redevelopment portfolio includes property expansion or conversion, pad building construction, residential unit construction, and non-residential construction. It also offers to lease and renting services. The trust's property portfolio includes Sylmar Towne Center, Assembly Row, Andorra Shopping Center, Azalea, Barcroft Plaza, Bethesda Row, Chesterbrook, Federal Plaza, and Gratiot Plaza. It has operations across Florida,...

    Add to Basket
  • Company Profile

    $295 | February 2024
    Company Profile

    MacroGenics Inc – Company Profile

    MacroGenics Inc (MacroGenics) is a biopharmaceutical company which focuses on the development and delivery of novel antibody-based therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders. Its product pipeline includes candidates for the treatment of solid tumors, HIV, breast and gastroesophageal cancers, type 1 diabetes, DART product candidates for the treatment of acute myeloid leukemia and myelodysplastic syndrome; and b-cell malignancies. The company’s product candidates are based on proprietary technology platforms, namely, Cancer Stem Cell Platform, Dual-Affinity Re-Targeting...

    Add to Basket
  • Company Profile

    $295 | January 2024
    Company Profile

    Argan Inc – Company Profile

    Argan Inc (Argan) is a holding company, which has businesses in the power, industrial, and construction sectors. Through its subsidiaries, the company provides a comprehensive range of services to the power industry, including engineering, procurement, and construction (EPC), of natural gas-fired power plants, and related commissioning, operations management, maintenance, project development, and consulting services. The company also provides telecommunications infrastructure services, as well as integrated fabrication, construction, and industrial plant services. It has operations in the US, Ireland, and the...

    Add to Basket
  • Company Profile

    $295 | January 2024
    Company Profile

    Choice Hotels International Inc – Company Profile

    Choice Hotels International Inc (Choice Hotels) operates hotel properties in the US and globally. The company provides a wide range of hotel services in the economy, mid-scale, and upscale segments. It operates hotels under several brands such as Comfort Suites, Quality, Comfort Inn, Econo Lodge, Clarion, Sleep Inn, MainStay Suites, Rodeway Inn, Cambria hotels & suites, Suburban Extended Stay Hotel, WoodSpring Suites, Clarion Pointe, Everhome Suites, and Ascend Hotel Collection. It also develops and sells cloud-based technology products including inventory...

    Add to Basket
  • Company Profile

    $295 | January 2024
    Company Profile

    CASI Pharmaceuticals Inc – Company Profile

    CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for treating cancer and other unmet medical needs. The company’s product EVOMELA (melphalan for injection) an intravenous formulation for the treatment of multiple myeloma. It’s pipeline product portfolio includes CID-103 for treatment of multiple myeloma; CNTC 19 for hematological malignancies; ZEVALIN for treatment of relapsed/refractory, low-grade B-cell non-Hodgkin’s lymphoma (NHL); MARQIBO for treatment of Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL); BI-1206...

    Add to Basket
  • Product Insights

    New
    $500 | April 2024
    Product Insights
    New

    Precision Biologics Inc Pipeline Insight and Competitive Landscape, 2023

    Empower your strategies with our Precision Biologics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Precision Biologics Inc (PBI), a subsidiary of NantWorks LLC, is a clinical-stage biotechnology company. The company offers cancer vaccines, antigens and antibodies, pipelines, diagnostics, therapeutics, clinical trials, tumor-specific antigens, companion diagnostic programs, and diagnostic biomarker for pancreatic and colorectal cancers. It provides services such as development of pharmaceutical and diagnostic products for the early detection and treatment of cancer...

  • Product Insights

    New
    $500 | April 2024
    Product Insights
    New

    Emergent BioSolutions Inc Pipeline Insight and Competitive Landscape, 2023

    Empower your strategies with our Emergent BioSolutions Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Emergent BioSolutions Inc (Emergent) is a life sciences company that provides specialized products to address medical needs and public health threats (PHTs). Its solutions help address PHTs including chemical, biological, radiological, nuclear and explosives (CBRNE), emerging infectious diseases, travel health, emerging health crises, and acute/emergency care. It offers vaccines, therapeutics, drug-device combination products, and contract development and manufacturing services....

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.